- Home
- TUSK vs NTHI Comparison
TUSK vs NTHI Comparison
Compare TUSK & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TUSK | NTHI |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.7M | 139.1M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | TUSK | NTHI |
|---|---|---|
| Price | $3.21 | $5.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 366.3K | 100.6K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 102.32 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $44,292,000.00 | N/A |
| Revenue This Year | $383.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $29.77 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.72 | $3.20 |
| 52 Week High | $3.48 | $12.99 |
Technical Indicators
Market Signals| Indicator | TUSK | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 50.14 |
| Support Level | $2.18 | $4.43 |
| Resistance Level | N/A | $5.70 |
| Average True Range (ATR) | 0.23 | 0.72 |
| MACD | 0.06 | 0.19 |
| Stochastic Oscillator | 79.35 | 54.55 |
Price Performance
Historical ComparisonAbout TUSK Mammoth Energy Services Inc.
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes rental services, infrastructure services, natural sand proppant services, accommodation services, and drilling services.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.